Neoprobe lands J&J as partner

May 13, 1998

Gamma probe developer Neoprobe has signed an agreement with Johnson & Johnson’s Ethicon Endo-Surgery division for sales and marketing of Neoprobe 1500, a portable radioisotope detector recently released by Neoprobe. Ethicon Endo-Surgery of

Gamma probe developer Neoprobe has signed an agreement with Johnson & Johnson’s Ethicon Endo-Surgery division for sales and marketing of Neoprobe 1500, a portable radioisotope detector recently released by Neoprobe. Ethicon Endo-Surgery of Cincinnati, OH, will have rights to promote Neoprobe 1500 and its reusable probes for one year in the U.S., and the two companies are in discussions over extending the deal to cover Europe, Japan, and Australia. Neoprobe of Dublin, OH, previously had an agreement with U.S. Surgical, but that deal broke down last year.